Correlation Between Praxis Precision and Milestone Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Praxis Precision and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Milestone Pharmaceuticals.

Diversification Opportunities for Praxis Precision and Milestone Pharmaceuticals

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Praxis and Milestone is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Praxis Precision i.e., Praxis Precision and Milestone Pharmaceuticals go up and down completely randomly.

Pair Corralation between Praxis Precision and Milestone Pharmaceuticals

Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 1.29 times more return on investment than Milestone Pharmaceuticals. However, Praxis Precision is 1.29 times more volatile than Milestone Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.2 per unit of risk. If you would invest  5,538  in Praxis Precision Medicines on September 3, 2024 and sell it today you would earn a total of  2,479  from holding Praxis Precision Medicines or generate 44.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Milestone Pharmaceuticals

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Milestone Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Praxis Precision and Milestone Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Milestone Pharmaceuticals

The main advantage of trading using opposite Praxis Precision and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.
The idea behind Praxis Precision Medicines and Milestone Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules